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Abstract - Medicinal plants maintain the health and vitality of individuals, and also have potential curative effect on vari-
ous diseases, including cancer. In this study were investigated the antiproliferative effects of water extracts of previously 
obtained ethanolic dry extracts of three different medicinal plants (Echinacea angustifolia, Salvia officinalis and Melissa 
officinalis) on cell lines derived from human cervix adenocarcinoma (HeLa cells). The best cytotoxic activity (IC50 = 43.52 
µg/ml) on HeLa cell lines was exhibited by Echinacea angustifolia. The extract of Salvia officinalis also showed a good 
cytotoxic activity against HeLa cell lines; the IC50 value was 70.41 µg/ml. Melissa officinalis manifested a slightly weaker 
cytotoxic activity and an IC50 value of 122.22 µg/ml. 
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INTRODUCTION
Every year, millions of people are diagnosed with 
cancer, leading to death. According to the Ameri-
can Cancer Society (ACS, 2006), deaths arising from 
cancer constitute 2-3% of the annual deaths recorded 
worldwide. Thus, cancer kills about 3.5 million peo-
ple annually all over the world. Several chemopre-
ventive agents are used to treat cancer, but they cause 
toxicity that prevents their usage (Kathiresan et al., 
2006). Cancer as the most invasive disease is the ob-
ject of intensive novel drug development but most 
of the used drugs have strong side effects, and due 
to the variety of cancer cells in the same patient and 
their fast mutation rate, it is very difficult to develop 
specific drugs (Barbaric et al., 2011). 
Because of the high death rate associated with 
cancer and because of the serious side effects of chem-
otherapy and radiation therapy, many cancer patients 
seek alternative and/or complementary methods of 
treatment. Plants have been used for treating vari-
ous diseases of human beings and animals since time 
immemorial.  They  maintain  the  health  and  vital-
ity of individuals, and also cure diseases, including 
cancer without causing toxicity. More than 50% of 
all modern drugs in clinical use are of natural prod-
ucts, many of which have the ability to control cancer 
cells (Rosangkima and Prasad, 2004). According to 
the estimates of the WHO, more than 80% of people 
in developing countries depend on traditional medi-
cine for their primary health needs. A recent survey 
shows that more than 60% of cancer patients use 
vitamins or herbs as therapy (Madhuri and Panday, 
2008; Sivalokanathan et al., 2005).
The use of naturally occurring dietary agents is 
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cancer growth (Waladkhani and Clemens, 1998; Or-
solic and Basic, 2005) and cancer prevention (Pan 
and Ho, 2008). Echinacea angustifolia, Salvia offici-
nalis and Melissa officinalis have been widely used 
and well-documented medicinal plants for centuries 
(Weiss, 1988; Hansel and Sticher, 2002). However, 
the anticancer properties of Echinacea angustifolia, 
Salvia officinalis and Melissa officinalis have not been 
fully investigated and proven. In this study, we inves-
tigated the antiproliferative properties of extracts of 
Echinacea angustifolia, Salvia officinalis and Melissa 
officinalis in the HeLa cell line derived from human 
cervix adenocarcinoma.
MATERIALS AND METHODS
Plant material
The  biological  source  of  Echinaceae  is  Echinacea 
angustifolia. The cultivated medicinal plant is from 
Serbia, Vojvodina, region of Apatin. The biological 
source  of  Salviae  is  Salvia  officinalis  from  Herze-
govina. The biological source of Melissae is Melissa 
officinalis. The cultivated medicinal plant is from the 
region of Pančevo in Serbia.   
Preparation of extracts
The first extraction was done in a percolator us-
ing 70% ethanol. Low-pressure evaporation of the 
extract was done following extraction. A 2 l glass 
percolator was first lined with some cotton wool 
and then filled with the desired amount of precut 
and sifted (0.75 sift) plant which was then covered 
with 70% ethanol. When the extract started to flow 
through the faucet on the percolator, the faucet was 
closed and the content left to macerate for at least 
16 h. Following maceration, the extract was poured 
out of the percolator at a speed of 2 l/h. The amount 
of the poured extract was six times the volume of 
the starting drug (1:6 extract). The extract was then 
stored for the next 3 to 5 days, filtered through a se-
ries of Whatman filters and finally passed through 
a 0.22 μm filter (Millipore, Billerica, MA). Subse-
quently, the extract was evaporated in a rotational 
vacuum  evaporator  until  a  dry  powder  was  ob-
tained. The temperature in the evaporator was kept 
below 65oC under a pressure of 15-25 mbar.
A second extraction was performed in order to 
obtain  water-soluble  components.  Previously  ob-
tained  dry  ethanolic  extracts  were  weighted  and 
mixed with physiological saline in a final concentra-
tion of 10 mg/mL. These suspensions were put in the 
dark at room temperature for 24 h; they were shaken 
for 3 h. Supernatants of suspensions were then filtered 
through 0.22 µm. The obtained water extracts, were 
used as stock solutions and were diluted with nutri-
ent medium to the various working concentrations.
Cell line
Human  cervix  adenocarcinoma  HeLa  cells  were 
obtained from the American Type Culture Collec-
tion (ATCC) (Manassas, VA, USA). HeLa cells were 
maintained in the recommended nutrition medium: 
(RPMI  1640  medium  supplemented  with  100  g/L 
heat-inactivated (56oC) fetal bovine serum (FBS), 3 
mmol/L L-glutamine, 100 µg/mL streptomycin, 100 
IU/mL penicillin and 25 mmol/L 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic  acid  (HEPES)  and  ad-
justed  to  pH  7.2  with  bicarbonate  solution.  Cells 
were grown in a humidified atmosphere of 5% CO2 
in air at 37oC.
Treatment of the cell line
Neoplastic HeLa (2000 cells per well) cells were seed-
ed into 96-well microtiter plates; 24 h later, after cell 
adherence, five different doubly diluted concentra-
tions of investigated water extracts were added to the 
wells. The final concentrations of extracts applied to 
target cells were 12.5, 25, 50, 100 and 200 μg/mL. 
Determination of cell survival
The  effect  of  extracts  on  target  cell  survival  was 
determined  by  the  microculture  tetrazolium  test 
(MTT) according to Mosmann (1983) with modifi-
cation by Ohno and Abe (1991), 72 h after addition 
of the compounds, as described earlier. Briefly, 20 μL 
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line) was added to each well. Samples were incubated 
for a further 4 h under the same conditions. Then 
100 μL of 100 g/L sodium dodecyl sulfate was added 
to dissolve formazan, a product from conversion of 
MTT dye by viable cells. The number of the viable 
cells in each well was proportional to the intensity of 
absorbance at 570 nm, measured in an ELISA plate 
reader 24 h later. To determine cell survival (%), the 
A of a sample with cells grown in the presence of 
various concentrations of the investigated extracts 
was divided by the control optical density (the A of 
control cells grown only in nutrient medium) and 
multiplied by 100. It was implied that the A of the 
blank was always subtracted from the A of the cor-
responding sample with target cells. The inhibitory 
concentration (IC50) was defined as the concentra-
tion of an agent that inhibits cell survival by 50 % 
compared with a vehicle-treated control. All IC50’s 
were reported as a mean of two measurements, each 
done in triplicate.
IC50 were established from dose-dependent data 
using Graphpad Prism Ver 3.0 software. 
RESULTS
In vitro antitumor activity
The cytotoxic action of Echinacea angustifolia, Salvia 
officinalis and Melissa officinalis extracts was tested 
on the HeLa cell line. The IC50 values of the studied 
extracts are presented in Table 1, while Fig. 1 depicts 
the cytotoxic curves from MTT assay showing the 
survival of HeLa cells grown for 72 h in the presence 
of increasing concentrations of extracts. The extract 
of Echinacea angustifolia exhibited the best cytotoxic 
activity. The IC50 on HeLa cell lines was 43.52 µg/ml. 
The extract of Melissa officinalis also showed a good 
cytotoxic activity against HeLa cell lines. The IC50 
value was 70.41 µg/ml. The Salvia officinalis extract 
manifested a slightly weaker cytotoxic activity. The 
IC50 value was 122.22 µg/ml.
Light microscopy
Results of microscopic examination (Carl Zeiss in-
verted microscopy, with total magnification 630) of 
the investigated HeLa cells after 72 h treatment with 
Echinacea angustifolia, Salvia officinalis and Melissa 
officinalis extracts are shown in Fig. 2. Extracts at a 
concentration of 200 µg/ml induced rounding, de-
tachment and decreased the number of HeLa cells, 
as compared to control cells.
DISCUSSION
In this study were investigated the antiproliferative 
effects of water extracts of obtained ethanolic extracts 
of three different medicinal plants (Echinacea angus-
tifolia, Salvia officinalis and Melissa officinalis) on cell 
Table 1. Concentrations of extracts that induced a 50% decrease 
in HeLa cell survival
Extracts
HeLa
IC50* (μg/ml)
Echinacea angustifolia 43.52 ± 0.01
Melissa officinalis 70.41 ± 0.91
Salvia officinalis 122.22 ± 3.30
Note: *IC50 values were obtained from the filtered extracts sus-
pensions, as described in Materials and Methods. IC50 values 
were expressed as the mean ± SD determined from the results of 
MTT assay in three independent experiments. 
Fig. 1. Representative graph of HeLa cells survival after 72 h cell 
growth in the presence of  increasing concentrations of investi-
gated extracts. 68 DESANKA CENIC-MILOSEVIC ET AL.
lines derived from human cervix adenocarcinoma 
(HeLa) cells. Echinacea angustifolia is a genus of her-
baceous flowering plants in the daisy family, Aster-
aceae. The generic name is derived from the Greek 
word ‘echino’, meaning sea urchin, due to the spiny 
central disk. Some species are used in plant medi-
cines and some are cultivated in gardens for their 
showy  flowers.  Echinacea  was  widely  used  by  the 
North American Plains Indians for its general me-
dicinal qualities (Wishart, 2004). Echinacea was one 
of the basic antimicrobial herbs of eclectic medicine 
from the mid 19th century through the early 20th 
century, and its use was documented for snakebite, 
anthrax and for relief of pain. In the 1930s, Echina-
cea became popular in both Europe and America as 
a plant medicine, but there was no evidence about its 
antiproliferative effects. Our results showed that Echi-
nacea at a concentration of around 43 µg/ml (43.52 ± 
0.01) inhibited HeLa cell survival by 50% compared 
with a vehicle-treated control. Photometric determi-
nation of phenols by spectrophotometer UV VIS HP 
8453 showed that the percent of phenols was 9.07%, 
in the used extract of Echinacea angustifolia. Chemi-
cal compounds called phenols are common to many 
other plants. Other chemical constituents that may 
be important in the health effects of Echinacea in-
clude alkylamides and polysaccharides. Alkylamides 
bind particularly to human CB2 and to a much lesser 
degree to CB1 cannabinoid receptors; as a result they 
are implicated in a variety of modulatory functions, 
including immune suppression, induction of apop-
tosis, cell migration and inhibition of tumor necrosis 
factor alpha (Raduner et al., 2006).
Salvia officinalis is a member of the family La-
miaceae and is native to the Mediterranean region, 
though it has naturalized in many places through-
out the world. It has a long history of medicinal and 
culinary use, and in modern times as an ornamen-
tal garden plant. The common name “sage” is also 
used for a number of related species. Salvia and 
sage are derived from the Latin salvere (to save), re-
ferring to the healing properties long attributed to 
the various Salvia species (Kintzios, 2004). Modern 
evidence shows possible uses as an anti-sweating 
agent,  antibiotic,  antifungal,  astringent,  antispas-
modic, estrogenic, hypoglycemic and tonic (Sage, 
2008). In a double blind, randomized and placebo-
controlled trial, sage was found to be effective in 
the management of mild to moderate Alzheimer’s 
disease (Akhondzadeh, 2003). There is no data on 
the antiproliferative effects of Salvia officinalis. Ac-
cording to the results of this study, Salvia officinalis 
in concentration of around 122 µg/ml (122.22±3.3) 
inhibits HeLa cell growth by 50% compared with 
a vehicle-treated control. Photometric determina-
tion of phenols by spectrophotometer UV VIS HP 
8453 showed that the percent of phenols is 12.5% in 
the used extract of Salvia officinalis. Other chemi-
cal constituents are tannic acid, oleic acid, ursonic 
acid, ursolic acid, cornsole, cornsolic acid, fumaric 
acid, chlorogenic acid, caffeic acid, niacin, nicoti-
namide, flavones, flavonoid glycosides and estro-
genic substances (Sage, 2008). The concentration of 
phenols is higher in Salvia officinalis (12.5%) than 
in Echinacea angustifolia (9.07%), but the antipro-
liferative effects of Echinacea angustifolia is better 
Fig. 2. Light microscopy of HeLa cells cultured with or without 
the 200µg/ml of extracts: A) control; B) Echinacea angustifolia; 
C) Salvia officinalis; and D) Melissa officinalis as described in 
Materials and Methods and photographed 72 h after the addi-
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than that of Salvia officinalis, which probably means 
that the other chemical constituents may be impor-
tant for antiproliferative effects, like alkylamides in 
Echinacea angustifolia and flavones and flavonoids 
in Salvia officinalis. 
Melissa officinalis (Lemon balm) is a perennial 
herb in the mint family Lamiaceae, native to south-
ern Europe and the Mediterranean region. Lemon 
balm is often used in cuisine, but is also used medici-
nally as a herbal tea or in extract form. It is claimed 
to have antibacterial and antiviral properties (it is ef-
fective against herpes simplex) (Kucera et al., 2006; 
Allahverdiyev et al., 2004; Schnitzler et al., 2008). Its 
antibacterial properties have also been demonstrat-
ed scientifically, although they are markedly weak-
er than those from a number of other plant studies 
(Nascimento et al., 2000). The extract of lemon balm 
was also found to have exceptionally high antioxi-
dant activity (Dastmalchi et al., 2008). Results of this 
study showed that Melissa officinalis in a concentra-
tion of around 70 µg/ml (70.41 ± 0.91) inhibits HeLa 
cell survival by 50% compared with a vehicle-treated 
control. Melissa officinalis contains eugenol, which 
kills bacteria, tannins that contribute to its antiviral 
effects, as well as terpenes, 1-octen-3-ol, 10-alpha-
cadinol, 3-octanol, 3-octanone, alpha-cubebene, al-
pha-humulene, beta-bourbonene, caffeic acid, cary-
ophyllene,  caryophyllene  oxide,  catechinene,  chlo-
rogenic  acid,  cis-3-hexenol,  cis-ocimene,  citral  A, 
citral B, citronellal, copaene, delta-cadinene, eugenyl 
acetate, gamma-cadinene, geranial, geraniol, geranyl 
acetate, germacrene D, isogeranial, linalool, luteolin-
7-glucoside,  methyl  heptenone,  neral,  nerol,  octyl 
benzoate,  oleanolic  acid,  pomolic  acid,  protocate-
chuic acid, rhamnazine, rosmarinic acid, rosmarinin 
acid, stachyose, succinic acid, thymol, trans-ocimene 
and ursolic acid.
CONCLUSION
Medicinal plants maintain the health and vitality of 
individuals, and also have potential curative effect 
on various diseases, including cancer. This study in-
vestigates the antiproliferative effects of extracts of 
Echinacea angustifolia, Salvia officinalis and Melissa 
officinalis on cell lines derived from human cervix 
adenocarcinoma (HeLa cells). The obtained results 
show that the best antiproliferative properties are ex-
hibited by Echinacea angustifolia, then Melissa offici-
nalis, and least of all, Salvia officinalis. An important 
goal of our future studies will be to investigate the 
antiproliferative effects and anticancer properties of 
other medicinal plants and propolis used in Serbian 
folk medicine. 
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